The newer and more expensive drugs rimegepant and ubrogepant — as well as another called lasmiditan, which can have drowsy ...

Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...

New migraine drugs less effective than traditional painkillers, triptans, according to global analysis in The BMJ.

Three newer migraine drugs were included in the analysis: lasmiditan (Reyvow), rimegepant (Nurtec), and ubrogepant (Ubrelvy).

The next frame shows the Ubrelvy logo in the backstage hallway along with a blue lit path. Frames six to seven then show Serena Williams walking down the blue lit path, no longer exhibiting migraine ...

The FDA (Food and Drug Administration) recently sent a letter expressing its dissatisfaction with a TV commercial featuring ...

The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...

A migraine medicine once-endorsed by Serena Williams has come under fire amid claims advertisements oversold it's usefulness.

Migraines and headaches affect billions of people worldwide, and a new study suggests the drug ubrogepant can put a stop to ...

A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure ...

The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...

According to a letter released by the FDA, the advertisement makes false or misleading claims about the drug's efficacy in treating migraine pain. The agency added that the ad exaggerates the speed ...